Tenofovir-associated kidney diseases and interactions between tenofovir and other antiretrovirals.
Lanzafame
Massimiliano
M
Lattuada
Emanuela
E
Rapagna
Francesca
F
Gottardi
Martina
M
Vento
Sandro
S
D058186:Acute Kidney Injury / Q000139:chemically induced*; D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000009:adverse effects* / Q000627:therapeutic use*; D000068698:Tenofovir
D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine